Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04481113
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2020-07-17
Brief Title:
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unilateral Breast Carcinoma |
| Anatomic Stage I Breast Cancer AJCC v8 |
| Anatomic Stage IA Breast Cancer AJCC v8 |
| Anatomic Stage IB Breast Cancer AJCC v8 |
| Anatomic Stage II Breast Cancer AJCC v8 |
| Anatomic Stage IIA Breast Cancer AJCC v8 |
| Anatomic Stage IIB Breast Cancer AJCC v8 |
| Anatomic Stage IIIA Breast Cancer AJCC v8 |
| HER2 Negative Breast Adenocarcinoma |
| Hormone Receptor Positive Breast Adenocarcinoma |
| Invasive Breast Carcinoma |
| Multifocal Breast Carcinoma |
| Prognostic Stage I Breast Cancer AJCC v8 |
| Prognostic Stage IA Breast Cancer AJCC v8 |
| Prognostic Stage IB Breast Cancer AJCC v8 |
| Prognostic Stage II Breast Cancer AJCC v8 |
| Prognostic Stage IIA Breast Cancer AJCC v8 |
| Prognostic Stage IIB Breast Cancer AJCC v8 |
| Prognostic Stage IIIA Breast Cancer AJCC v8 |
| Prognostic Stage IIIB Breast Cancer AJCC v8 |
Keywords: